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Paraquat is highly toxic to humans. Peak plasma levels are reached within 1 hour after intentional
ingestion of this poison, followed by a rapid decline because of its distribution to the extravascular
compartment and renal elimination. It induces generation of free oxygen radicals and consumption of
intracellular nicotinamide adenine dinucleotide phosphate in a cyclic single-electron reduction/oxida-
tion reaction; consequently, cell death occurs because of lipid peroxidation of the cell membrane.
Paraquat selectively accumulates in the lungs, resulting in pulmonary ﬁbrosis, which can eventually lead
to respiratory failure in many survivors of the acute phase. It is believed that charcoal hemoperfusion is
the best modality for extracorporeal elimination in the acute phase. Afterward, anti-inﬂammatory and
immunosuppressive treatment and even lung radiotherapy have been proposed to alleviate inﬂamma-
tion. Unfortunately, these protocols are unsuccessful in a majority of patients. Because the ﬁrst hours are
critical for treatment and the lungs are the target organs, pulmonary salvage is the aim of the toxicol-
ogist. Deep insertion of an endotracheal tube as the ﬁrst treatment effort can produce alveolar collapse,
as well as an arteriovenous pulmonary shunt in one lung. Decreased paraquat uptake, at least in one
lung, leads to a reduced inﬂammatory process in the treated lung after the acute phase of toxicity.
Furthermore, preserving a functioning lung is sufﬁcient for life.
Copyright © 2015, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC. All
rights reserved.1. Introduction
Paraquat (1,10-dimethyl-4,40-bipyridinium dichloride) is an
herbicide used to destroy shallow-rooted vegetation on farms.
Accidental or intentional ingestion when attempting suicide is the
usual reason for toxicity [1]. Paraquat is rapidly absorbed after
ingestion and peak plasma levels are reached within 1 hour, fol-
lowed by a rapid decline because of its distribution to the, Children's Medical Center
Gharib Street, Tehran, Iran.
rabadi).
elief Tzu Chi Foundation. Publisheextravascular compartment. About 90% of the absorbed toxin is
eliminated by renal excretion as the parent compound within the
ﬁrst 24 hours [2,3]. Unfortunately, renal cells are vulnerable to the
toxic compound and paraquat-induced kidney injury leads to
deterioration of renal function within the ﬁrst few hours [2]. The
toxin compound then accumulates in target organs. Paraquat
selectively accumulates in the lungs through the polyamine uptake
system [4]. It induces generation of free oxygen radicals as well as
consumption of intracellular nicotinamide adenine dinucleotide
phosphate in a cyclic single-electron reduction/oxidation (redox)
reaction; consequently, cell death occurs because of lipid peroxi-
dation of the cell membrane [2,5e7]. The parent toxic molecule
reproduces in this redox reaction, resulting in a cascade of pul-
monary cellular damage [8].d by Elsevier Taiwan LLC. All rights reserved.
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There is no speciﬁc antidote for paraquat poisoning. In moderate
to severe poisoning, death occurs within the ﬁrst few days because
of multiorgan dysfunction [2,9]. The amount of ingested paraquat is
the most important prognostic factor. Severe poisoning after
ingestion of > 100 mL of a 20% product may result in cardiac arrest
within the ﬁrst 24 hours; ingestion of 50e100 mL may result in
renal and respiratory failure, with death occurring within the ﬁrst 7
days. By contrast, ingestion of 15e50 mL of a 20% product may
result in gradual respiratory failure due to pulmonary ﬁbrosis
within the 1st month. However, corrosive effects may be the sole
presentation after consumption of a small amount and complete
recovery after ingestion of < 15 mL is conceivable [2,10].
In a study by Gil et al [11], no patient with a plasma paraquat
level of 3.44 mg/mL 2 hours after ingestion survived despite
aggressive treatment; however, the lowest plasma paraquat level in
nonsurvivors was 0.92 mg/mL at 2 hours.
3. Current treatment protocols
Paraquat is a water-soluble salt, which has a relatively large
volume of distribution (1.0e1.5 L/kg body weight) [2,12]. Charcoal
hemoperfusion, especially in the ﬁrst hours, increases the elimi-
nation rate of paraquat from the plasma [13]. Because the toxic
effects of paraquat occur through production of reactive oxygen
species (ROS) as well as depletion of glutathione, it is proposed that
antioxidant therapymay alleviate subsequent tissue injury [14e17].
The alveolar oxygen pressure has an important role in ROS pro-
duction within pneumocytes [18]. In moderate toxicity, gradual
respiratory dysfunction is expected if the patient survives the initial
insult. The main cause is pulmonary ﬁbrosis due to the inﬂamma-
tory process after alveolar cell damage. Hence, anti-inﬂammatory
drugs such as high-dose steroids, immunosuppressive agents
such as cyclophosphamide, and even lung radiotherapy have been
applied in several studies with varying success rates [17,19e21].
Lung transplantation is the only curative strategy for pulmonary
ﬁbrosis [22]. However, transplantation is not readily available and
prevention of lung ﬁbrosis is still the main treatment by clinical
toxicologists.
4. Lung circumvention
Because pulmonary scavenging of paraquat during the ﬁrst
hours of systemic hemoperfusion is not sufﬁcient, an inﬂammatory
process is predictable in moderate cases. In fact, the polyamine
uptake system in the lungs continues competitive recruitment of
paraquat against the plasma concentration gradient during
hemoperfusion. Prompt accumulation of the parent toxin leads to
steady alveolar cell damage despite a decrease in the plasma levelFigure 1. Deep insertion of the endotracheal tube can produce alveolar collapse, as well as a
toxin reuptake.of the toxin after extracorporeal elimination. Therefore, engen-
dering an iatrogenic pulmonary shunt before hemoperfusion may
alleviate pulmonary uptake and enhance lung preservation. This is
achieved by deep insertion of an endotracheal tube, which leads to
alveolar collapse as well as an arteriovenous pulmonary shunt in
one lung [23,24]. This blocks the uptake of more toxins (Figure 1).
Furthermore, preserving a functioning lung is sufﬁcient for life. A
lung-separation technique was ﬁrst reported by Gefﬁn et al in 1969
[25]. They established intubation of one main bronchus for resec-
tion of distal tracheal and carinal tumors. Nowadays, lung-
separation techniques are widely used for surgical operations on
the pulmonary tree, to bypass a tracheobronchial injury site, and
for protection against contralateral pulmonary secretions [26,27].
5. Evaluation of this therapeutic intervention
Selective recruitment of paraquat through the polyamine uptake
system results in lung concentrations about 10-fold greater than
that in the plasma compartment [4,28,29]. If the patient survives
the acute phase, pulmonary ﬁbrosis in relation to cellular oxidative
damage is the main pathophysiological development after moder-
ate paraquat intoxication. This condition represents a refractory
hypoxemia [2,20]. In the literature, researchers have only focused
on alleviation of toxin-induced oxidative stress or inﬂammatory
processes following the acute phase [17,20,21,28e32]. Hoffer et al
[14] indicated that N-acetyl-L-cysteine (NAC) has protective prop-
erties against the cytotoxicity of paraquat in alveolar type II cells in
a rat model. Another study conducted by Hong et al [15] showed
that 10 mmol of NAC suppressed ROS formation in paraquat
poisoning. As the HabereWeiss reaction is deemed to have a role in
free radical-induced oxidative stress, iron-chelating therapy has
been proposed as another treatment modality in acute paraquat
intoxication [16]. In a series of studies, Lin et al [17,19,31] evaluated
repeated pulse steroids and immunosuppressive agents and indi-
cated improvement in the survival of their patients. Some authors
have tried hypooxygenation to reduce ROS production [33,34].
Unfortunately, these protocols have been unsuccessful in a majority
of patients [35]. We believe that if the treatment protocol focuses
on the attenuation of pulmonary toxin recruitment during the
acute phase, a reduced inﬂammatory process can be expected. We
feel that circumvention of one lung before applying extracorporeal
toxin removal methods can preferentially suppress paraquat up-
take by lung cells. Much evidence shows that perfusion of non-
ventilated parts of the lung will induce intrapulmonary
arteriovenous shunting, which is associated with a ven-
tilationeperfusion mismatch. This condition is tolerated by the
patient and only some degree of hypoxia results [36].
So far, no study has investigated iatrogenic lung circumvention
as a treatment protocol in any situation. Available information
shows that after obstruction of the main bronchus, functionalrteriovenous pulmonary shunt in one lung, which is responsible for prohibition of more
S.M. Marashi et al. / Tzu Chi Medical Journal 27 (2015) 99e101 101intrapulmonary shunting and absorption atelectasis develop
[37,38]. However, these studies do not prove that one-lung bypass
enhances the elimination of pretreatment-absorbed toxins, or di-
minishes selective uptake of paraquat and increases wipe out of
oxygen molecules in the treated lung. Gil et al [11] showed a pro-
gressive decrease in the plasma paraquat level during the ﬁrst
hours of intoxication. Proudfoot et al [39] showed a correlation
between plasma paraquat levels over time and the survival of
patients.6. Conclusion
Patient deaths in moderate paraquat toxicity are directly related
to pulmonary ﬁbrosis. Less cellular damage and a reduced inﬂam-
matory process are related to a lower alveolar microcirculatory
paraquat level. This condition is conceivable with intrapulmonary
arteriovenous shunting. Furthermore, occasionally emergency
charcoal hemoperfusion, which is thought to be the best modality
for extracorporeal elimination, is not available promptly. Therefore,
many patients do not receive appropriate treatment at the proper
time. By contrast, endotracheal intubation is a relatively safe pro-
tocol, which is achievable in locations with trained emergency
personnel. Deep endotracheal intubation as the ﬁrst treatment
effort can decrease paraquat uptake in at least in one lung; there-
fore, we can expect a reduced inﬂammatory process and dimin-
ished ﬁbrotic changes in the treated lung after the acute phase of
toxicity. All of this evidence could lead to a new treatment protocol
in the management of acute paraquat toxicity. However, the
ventilated lung will be sacriﬁced, preserving one functioning lung,
which is sufﬁcient for life.References
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